- Home
- GRX vs NOTV Comparison
GRX vs NOTV Comparison
Compare GRX & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- NOTV
- Stock Information
- Founded
- GRX 2007
- NOTV 1974
- Country
- GRX United States
- NOTV United States
- Employees
- GRX N/A
- NOTV N/A
- Industry
- GRX Finance/Investors Services
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- NOTV Health Care
- Exchange
- GRX Nasdaq
- NOTV Nasdaq
- Market Cap
- GRX 164.6M
- NOTV 144.3M
- IPO Year
- GRX N/A
- NOTV 1997
- Fundamental
- Price
- GRX $10.37
- NOTV $4.50
- Analyst Decision
- GRX
- NOTV Strong Buy
- Analyst Count
- GRX 0
- NOTV 3
- Target Price
- GRX N/A
- NOTV $5.92
- AVG Volume (30 Days)
- GRX 39.7K
- NOTV 602.3K
- Earning Date
- GRX 01-01-0001
- NOTV 02-05-2025
- Dividend Yield
- GRX 5.98%
- NOTV N/A
- EPS Growth
- GRX N/A
- NOTV N/A
- EPS
- GRX 0.26
- NOTV N/A
- Revenue
- GRX N/A
- NOTV $490,739,000.00
- Revenue This Year
- GRX N/A
- NOTV $7.14
- Revenue Next Year
- GRX N/A
- NOTV $5.73
- P/E Ratio
- GRX $38.50
- NOTV N/A
- Revenue Growth
- GRX N/A
- NOTV N/A
- 52 Week Low
- GRX $7.73
- NOTV $1.23
- 52 Week High
- GRX $10.40
- NOTV $11.42
- Technical
- Relative Strength Index (RSI)
- GRX 66.23
- NOTV 51.02
- Support Level
- GRX $9.62
- NOTV $4.27
- Resistance Level
- GRX $10.48
- NOTV $4.69
- Average True Range (ATR)
- GRX 0.14
- NOTV 0.39
- MACD
- GRX 0.07
- NOTV -0.03
- Stochastic Oscillator
- GRX 83.33
- NOTV 60.22
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.